CpG oligodeoxynucleotides (NBP2-26237): Novus Biologicals
CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
Vaccines | Free Full-Text | Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen | Bioconjugate Chemistry
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Publikationen von Prof. Jeltsch | Institut für Biochemie und Technische Biochemie | Universität Stuttgart
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based Nanomaterials | Nano Letters
CpG oligodeoxynucleotide - Wikipedia
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Frontiers | Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Frontiers | Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
Development of the CpG Adjuvant 1018: A Case Study | SpringerLink
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques | Science Advances
DNA methylation enables transposable element-driven genome expansion | PNAS
CpG ODN (1826), TLR9 ligand (Class B) | Abeomics | Biomol.de
Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses | PLOS ONE
Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses - ScienceDirect
Targeting natural killer cells to enhance vaccine responses: Trends in Pharmacological Sciences
